Advertisement

Topics

Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed ...

03:06 EDT 31 Jul 2017 | BioMedReports - Blog
Teva Pharmaceutical Industries Ltd.
IR Contacts:
United States
Kevin C. Mannix, 215-591-8912
Ran Meir, 215-591-3033
or
Israel
Tomer Amitai, 972 (3) 926-7656
or
PR Contacts:
Israel
Iris Beck Codner, 972 (3) 926-7208
or
United States
Denise Bradley, 215-591-8974
Nancy Leone, 215-284-0213
or
Celltrion, Inc.
IR Contact:
Republic of Korea
Josh Hwang, 82-32-850-5171
Josh.Hwang@celltrion.com
or
PR Contact:
Republic of Korea
Gunhyuk Lee, 82-32-850-5168
Gunhyuk.Lee@celltrion.com

Read more...

Original Article: Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed ...

NEXT ARTICLE

More From BioPortfolio on "Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed ..."

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...